Northwest Biotherapeutics Inc NWBO

Healthcare Biotechnology

Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. It has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct, is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and included treatment of a diverse range of more than a dozen types of cancers. The Company’s wholly owned subsidiaries include Flaskworks, LLC, Northwest Biotherapeutics Limited, Aracaris Capital, Ltd, Northwest Biotherapeutics B.V., and NW Bio GmbH.

OTCQB:NWBO - Post by User

Northwest Biotherapeutics Inc

Bullboard Posts

Post by pericles1on Jan 14, 2016 12:33pm

891 Views

Post# 24458353

Bought some today!

I'm still very unhappy with the hold on enrollment and it's taking way to long to resolve! But everything has a price and below two seems like a good speculation to me. Started to increase my small remaining position. I still think their is a good chance they will make their four month target in phase III. I hope that Linda can clear things up soon and am willing to make the bet. It does seem that the love affair between Woodword and Linda is over. At this price he is stuck, but good!

Bullboard Posts

This battery metals stock is on a path to the global stage